GH Research PLC (GHRS)
NASDAQ·Healthcare·Biotechnology
$25.96
-6.78%
Mkt Cap $1.78B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (13 analysts)
$41.50
Range $32.00 – $65.00
Implied Upside
+59.9%
Consensus $41.50 vs current $25.96
NASDAQ·Healthcare·Biotechnology
$25.96
-6.78%
Mkt Cap $1.78B
Buy
5
Hold
0
Sell
0
Price Target (13 analysts)
$41.50
Range $32.00 – $65.00
+59.9%
Consensus $41.50 vs current $25.96